A novel approach for predicting the dissolution profiles of pharmaceutical tablets

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Raphael PausYuanhui Ji

Abstract

In this paper, the intrinsic dissolution profiles of naproxen (NAP) at pH values of 1.5 and 3.0 and of trimethoprim (TMP) at pH values of 1.5, 3.0, 5.0, 6.5 and 7.2 were measured. Meanwhile, the dissolution profiles of NAP and TMP from cylindrical tablets were measured at different temperatures (298.15K, 305.15K, 301.15K and 310.15K) and stirring speeds (50rpm, 100rpm and 150rpm) as well as at different pH values (1.5, 3.0, 5.0, 6.5 and 7.2). Additionally the pH-dependent solubilities of both APIs were measured and modeled. The chemical-potential-gradient model combined with the perturbed-chain statistical associating fluid theory (PC-SAFT) was applied to predict the dissolution profiles of the cylindrical tablets of NAP and TMP under different conditions based on the analysis of their intrinsic dissolution profiles as well as on the determination of the surface-area reduction of the API tablets during dissolution. It was shown that the predicted dissolution profiles of the tablets under different conditions were in a good accordance with the experimental findings.

References

Dec 1, 1972·Journal of Pharmaceutical Sciences·S F Kramer, G L Flynn
Jan 1, 1981·Journal of Pharmaceutical Sciences·K G MooneyV J Stella
Jan 1, 1981·Journal of Pharmaceutical Sciences·K G MooneyV J Stella
Jan 1, 1997·Journal of Pharmaceutical Sciences·I KatzhendlerM Friedman
Jun 1, 1997·Journal of Pharmaceutical Sciences·L P de AlmeidaM Figueiredo
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
May 23, 2001·Advanced Drug Delivery Reviews·J Siepmann, A Göpferich
Feb 19, 2005·Critical Reviews in Therapeutic Drug Carrier Systems·Deenu G Kanjickal, Stephanie T Lopina
Oct 24, 2006·Drug Discovery Today·Shobha N BhattacharJames A Wesley
Nov 4, 2006·Advanced Drug Delivery Reviews·Chien-Chi Lin, Andrew T Metters
Nov 14, 2006·Advanced Drug Delivery Reviews·Davis Yohanes ArifinChi-Hwa Wang
Sep 30, 2008·International Journal of Pharmaceutics·J Siepmann, F Siepmann
Mar 14, 2009·Journal of Pharmaceutical Sciences·Feelly Ruether, Gabriele Sadowski
Aug 9, 2011·Journal of Chromatography. a·Juan M PallicerElisabeth Bosch
May 25, 2012·The Journal of Physical Chemistry. B·Thomas ReschkeGabriele Sadowski
May 30, 2014·Molecular Pharmaceutics·Anke PrudicGabriele Sadowski
Oct 9, 2014·Molecular Pharmaceutics·Anke PrudicGabriele Sadowski
Feb 27, 2015·Pharmaceutical Research·Yuanhui JiGabriele Sadowski
Mar 10, 2015·International Journal of Pharmaceutics·Raphael PausYuanhui Ji
Mar 21, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anke PrudicGabriele Sadowski

❮ Previous
Next ❯

Citations

Jul 23, 2016·International Journal of Pharmaceutics·Aoi AriyasuMakoto Otsuka
Jun 7, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rania O SalamaPaul M Young

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.